These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36625664)

  • 21. Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria.
    Cavassin ED; de Figueiredo LF; Otoch JP; Seckler MM; de Oliveira RA; Franco FF; Marangoni VS; Zucolotto V; Levin AS; Costa SF
    J Nanobiotechnology; 2015 Oct; 13():64. PubMed ID: 26438142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Efficacy of Imipenem Conjugated with Synthesized Silver Nanoparticles Against Acinetobacter baumannii Clinical Isolates, Iran.
    Zendegani E; Dolatabadi S
    Biol Trace Elem Res; 2020 Sep; 197(1):330-340. PubMed ID: 31701463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Omega-3 Fatty Acids on the Evolution of Acinetobacter baumannii Drug Resistance.
    Zang M; Adams FG; Hassan KA; Eijkelkamp BA
    Microbiol Spectr; 2021 Dec; 9(3):e0145521. PubMed ID: 34762519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acinetobacter baumannii NCIMB8209: a Rare Environmental Strain Displaying Extensive Insertion Sequence-Mediated Genome Remodeling Resulting in the Loss of Exposed Cell Structures and Defensive Mechanisms.
    Repizo GD; Espariz M; Seravalle JL; Díaz Miloslavich JI; Steimbrüch BA; Shuman HA; Viale AM
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32727858
    [No Abstract]   [Full Text] [Related]  

  • 26. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
    Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
    mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability.
    Stracquadanio S; Bonomo C; Marino A; Bongiorno D; Privitera GF; Bivona DA; Mirabile A; Bonacci PG; Stefani S
    Microbiol Spectr; 2022 Oct; 10(5):e0234722. PubMed ID: 36173300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescence-Based Detection of Natural Transformation in Drug-Resistant Acinetobacter baumannii.
    Godeux AS; Lupo A; Haenni M; Guette-Marquet S; Wilharm G; Laaberki MH; Charpentier X
    J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30012729
    [No Abstract]   [Full Text] [Related]  

  • 29. Mimusops elengi Flower-Mediated Green Silver Nanoparticles Control Staphylococcus aureus and Acinetobacter baumannii.
    J CN; S R; S H
    Appl Biochem Biotechnol; 2022 Jul; 194(7):3066-3081. PubMed ID: 35347673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii.
    Wan G; Ruan L; Yin Y; Yang T; Ge M; Cheng X
    Int J Nanomedicine; 2016; 11():3789-800. PubMed ID: 27574420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms Protecting
    Monem S; Furmanek-Blaszk B; Łupkowska A; Kuczyńska-Wiśnik D; Stojowska-Swędrzyńska K; Laskowska E
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752093
    [No Abstract]   [Full Text] [Related]  

  • 32. Phenotypic Characterization and Heterogeneity among Modern Clinical Isolates of Acinetobacter baumannii.
    Valcek A; Philippe C; Whiteway C; Robino E; Nesporova K; Bové M; Coenye T; De Pooter T; De Coster W; Strazisar M; Van der Henst C
    Microbiol Spectr; 2023 Feb; 11(1):e0306122. PubMed ID: 36475894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evasion of Antimicrobial Activity in
    Martínez-Trejo A; Ruiz-Ruiz JM; Gonzalez-Avila LU; Saldaña-Padilla A; Hernández-Cortez C; Loyola-Cruz MA; Bello-López JM; Castro-Escarpulli G
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743027
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular mechanisms of antimicrobial resistance in Acinetobacter baumannii, with a special focus on its epidemiology in Lebanon.
    Jamal S; Al Atrouni A; Rafei R; Dabboussi F; Hamze M; Osman M
    J Glob Antimicrob Resist; 2018 Dec; 15():154-163. PubMed ID: 29859266
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Nodari CS; Fuchs SA; Xanthopoulou K; Cayô R; Seifert H; Gales AC; Dilthey A; Higgins PG
    mSphere; 2021 Dec; 6(6):e0074621. PubMed ID: 34851165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
    Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
    Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Green synthesized silver nanoparticles by marine endophytic fungus Penicillium polonicum and its antibacterial efficacy against biofilm forming, multidrug-resistant Acinetobacter baumanii.
    Neethu S; Midhun SJ; Radhakrishnan EK; Jyothis M
    Microb Pathog; 2018 Mar; 116():263-272. PubMed ID: 29366864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptidoglycan Recycling Promotes Outer Membrane Integrity and Carbapenem Tolerance in Acinetobacter baumannii.
    Islam N; Kazi MI; Kang KN; Biboy J; Gray J; Ahmed F; Schargel RD; Boutte CC; Dörr T; Vollmer W; Boll JM
    mBio; 2022 Jun; 13(3):e0100122. PubMed ID: 35638738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acinetobacter baumannii: Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline.
    Dehbanipour R; Ghalavand Z
    J Clin Pharm Ther; 2022 Nov; 47(11):1875-1884. PubMed ID: 36200470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.